摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(hexahydro-2,5-methanopentalen-3a(1H)-ylcarbonyl)amino]-N-[(3R)-tetrahydrofuran-3-yl]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxamide | 1101855-87-1

中文名称
——
中文别名
——
英文名称
2-[(hexahydro-2,5-methanopentalen-3a(1H)-ylcarbonyl)amino]-N-[(3R)-tetrahydrofuran-3-yl]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxamide
英文别名
N-[(3R)-oxolan-3-yl]-2-(tricyclo[3.3.1.03,7]nonane-3-carbonylamino)-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide
2-[(hexahydro-2,5-methanopentalen-3a(1H)-ylcarbonyl)amino]-N-[(3R)-tetrahydrofuran-3-yl]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxamide化学式
CAS
1101855-87-1
化学式
C22H28N2O4S
mdl
——
分子量
416.541
InChiKey
NOPRHQIDRZVFCZ-DDBYQKKSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    29
  • 可旋转键数:
    4
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    105
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS
    申请人:Carroll William A.
    公开号:US20090018114A1
    公开(公告)日:2009-01-15
    The present application relates to cannabinoid receptor ligands containing compounds of formula (I) wherein A, R 1 , R 2 , and R 3 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
    本申请涉及含有式(I)化合物的大麻素受体配体,其中A、R1、R2和R3如规范中所定义。本申请还涉及包含这种化合物的组合物,以及使用这种化合物和组合物治疗疾病和疾病的方法。
  • US8338623B2
    申请人:——
    公开号:US8338623B2
    公开(公告)日:2012-12-25
  • [EN] NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS<br/>[FR] COMPOSÉS NOVATEURS EN TANT QUE LIGANDS DE RÉCEPTEUR DE CANNABINOÏDES
    申请人:ABBOTT LAB
    公开号:WO2009009550A1
    公开(公告)日:2009-01-15
    The present application relates to cannabinoid receptor ligands containing compounds of formula (I) wherein A, R1, R2, and R3 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
查看更多

同类化合物

化合物SEP-363856HYDROCHLORIDE 6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-甲胺 6,7-二氢-4H-噻吩并[3,2-c]吡喃-2-羧酸乙酯 6,7-二氢-4H-噻吩并[3,2-c]吡喃-2-羧酸 5,7-二氢-4H-噻吩并[2,3-c]吡喃-3-羧酸 5,7-二氢-4H-噻吩并[2,3-C]吡喃-3-羧酸乙酯 4-(2-羟基乙基)-4-甲基-6,7-二氢-4h-噻吩并[3,2-c]吡喃 4,5-二氢螺[哌啶-4,7-噻吩并[2,3-c]吡喃] 4',5'-二氢-螺[哌啶-4,7'-[7H]噻吩并[2,3-c]吡喃]-1-羧酸叔丁酯 2-氯-4,5-二氢螺[哌啶-4,7-噻吩并[2,3-c]吡喃] 2-氨基-5,5-二甲基-4,7-二氢-5H-噻吩并[2,3-C]吡喃-3-羧酸叔丁酯 2-氨基-4,7-二氢-5H-噻吩并[2,3-c]吡喃-3-羧酸乙酯 2-氨基-4,7-二氢-5H-噻吩并[2,3-c]吡喃-3-甲腈 2-[[(苯甲酰基氨基)硫代甲酰]氨基]-4,7-二氢-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸 (4-甲基-6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-基)乙酸 (2-羧基噻吩-3-基)乙酸酐 2-((8-fluoro-5-methylchroman-6-yl)methyl)-N-methylbenzamide 2,4-(2,5,8,11-tetraoxa)dodecano-3-bromo-5-phenylthiophene 2-(cycloheptanecarbonyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid 2-(Cyclopentanecarbonyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid ethyl ester 2-[(hexahydro-2,5-methanopentalen-3a(1H)-ylcarbonyl)amino]-N-[(3R)-tetrahydrofuran-3-yl]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxamide N-[5-(4-cyanophenyl)methyl-2-thiazolyl]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxamide 6,7-dihydro-N-methyl-4H-Thieno[3,2-c]pyran-4-methanamine hydrochloride 5-Methyl-7-oxo-4,5-dihydro-7H-thieno<2.3-c>pyran 5,7-dihydro-7-(4-nitrophenyl)-4H-thieno[2,3-c]pyran 1,9-Dimethyl-4,6-dihydrodithieno<3,4-c:3',4'-e>oxepin-4-on N-(3-cyano-5,7-dihydro-4H-thieno[2,3-c]pyran-2-ylcarbamoyl)benzamide {4-methyl-4,6-dihydrothieno[2,3-c]furan-2-yl}hexahydro-2,5-methanopentalene-3a(1H)-carboxylic acid N-benzoyl-N'-(3-cyano-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)thiourea 5,7-dihydro-7,7-dimethyl-4H-thieno[2,3-c]pyran 5,7-dihydro-7-pentyl-4H-thieno[2,3-c]pyran 3-(benzo[d]thiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyran-2-amine (2-ethyl-6,7-dihydro-4H-thieno[3,2-c]pyran-4-yl)methanamine hydrochloride 2-Bromo-5,5-dimethyl-5H-thieno<3,2-b>pyran